Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a -19.005\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a: CC1CCN(C(=O)CSc2nnc3c(n2)[nH]c2ccc(F)cc23)CC1
b: O=C(N1CCCCC1)C1(S(=O)(=O)c2ccccc2)CC=CC1
Answer: a. CC1CCN(C(=O)CSc2nnc3c(n2)[nH]c2ccc(F)cc23)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC1CCN(C(=O)CSc2nnc3c(n2)[nH]c2ccc(F)cc23)CC1
CC1CCN(C(=O)CSc2nnc3c(n2)[nH]c2ccc(F)cc23)CC1
2-[(8-fluoro-5H-[1,2,4]triazino[5,6-b]indol-3-yl)sulfanyl]-1-(4-methylpiperidin-1-yl)ethanone